Caspase activation and changes in Bcl-2 family member protein expression associated with E2F-1-mediated apoptosis in human esophageal cancer cells

Clinical Cancer Research

Volumn 6, Issue 4, 2000, Pages 1579-1589

  Yang, Hai Liang ^a   Dong, Yan Bin ^a   Elliott, Mary Jane ^a   Liu, Ta Jen ^b   McMasters, Kelly M ^a  

^a UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; PROTEIN BCL 2; TRANSCRIPTION FACTOR E2F;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL DEATH; CONTROLLED STUDY; ENZYME ACTIVATION; ESOPHAGUS CANCER; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ADENOVIRIDAE; APOPTOSIS; BCL-X PROTEIN; CARRIER PROTEINS; CASPASES; CELL CYCLE; CELL CYCLE PROTEINS; CELL DEATH; CELL DIVISION; CELL SURVIVAL; DNA, RECOMBINANT; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; E2F1 TRANSCRIPTION FACTOR; ENZYME ACTIVATION; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC VECTORS; HUMANS; NEOPLASM PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR DP1; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0000303284     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Ries, L. A. G., Kosary, C. L., Hankey, B. F., Miller, B. A., and Edwards, B. K. (eds). SEER Cancer Statistic Review, 1973-1995. Bethesda, MD: National Cancer Institute, 1998.
2. National Center for Health Statistics. Vital Statistics of the United States, 1994, Vol. 2, Part A. Washington: Public Health Service, 1998.
3. Kosary, C. L., Ries, L. A. G., Miller, B. A., Hankey, B. F., and Edwards, B. K. SEER Cancer Statistics Review, 1973-1992: Tables and Graphs (NIH Publ. No. 95-289), Bethesda. MD: National Cancer Institute, 1995.
4. Schrump, D. S., and Roth, J. A. Molecular biology and immunology of lung and esophageal cancer. In: A. E. Beaue, A. S. Geha, G. L. Hammond, H. Laks, and K. S. Naunheim (eds.), Glenn's Thoracic and Cardiovascular Surgery, pp. 331-343. East Norwalk, CT: Appleton & Lange, 1995.
5. Montesano, R., Hollstein, M., and Hainaut, P. Genetic alterations in esophageal cancer and their relevance to etiology and pathogenesis: a review. Int. J. Cancer, 69: 225-235, 1996.
6. Senmaru, N., Shichinohe, T., Takeuchi, M., Miyamoto, M., Sazawa, A., Ogiso, Y., Takahashi, T., Okushiba, S., Takimoto, M., Kato, H., and Kuzumaki, N. Suppression of Erk activation and in vivo growth in esophageal cancer cells by the dominant negative Ras mutant, N116Y. Int. J. Cancer, 78: 366-371, 1998.
7. Huang, Y., Boynto, R. F., Blount, P. L., Silverstein, R. J., Yin, J., Tong, Y., McDaniel, T. K., Newkirk, C., Resau, J. H., Sridhara, R., Reid, B. J., and Meltzer, S. J. Loss of heterozygosity involves multiple tumor suppressor genes in human esophageal cancers. Cancer Res., 52: 6525-6530, 1992.
8. Huang, Y., Meltzer, S. J., Yin, J., Tong, Y., Chang, E. H., Srivastava, S., McDaniel, T., Boynton, R. F., and Zou, Z. Q. Altered messenger RNA and unique mutational profiles of p53 and Rb in human esophageal carcinomas. Cancer Res., 53: 1889-1894, 1993.
9. Jiang, W., Zhang, Y. J., Kahn, S. M., Hollstein, M. C., Santella, R. M., Lu, S. H., Harris, C. C., Montesano, R., and Weinstein, I. B. Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer. Proc. Natl. Acad. Sci. USA, 90: 9026-9030, 1993.
10. Dyson, N. The regulation of E2F-1 by pRB-family proteins. Genes Dev., 12: 2245-2262, 1998.
11. Helin, K. Regulation of cell proliferation by the E2F transcription factors. Curr. Opin. Gen. Dev., 8: 28-35, 1998.
12. Johnson, D. G., Schwartz, J. K., Cress, W. D., and Nevins, J. R. Expression of transcription factor E2F-1 induces quiescent cells to enter S phase. Nature (Lond.), 365: 349-352, 1993.
13. Xu, G., Livindston, D. M., and Krek, W. Multiple members of the E2F transcription factor family are the products of oncogenes. Proc. Natl. Acad. Sci. USA, 92: 1357-1361, 1995.
14. Pierce, A. M., Fisher, S. M., Conti, C. J., and Johnson, D. G. Deregulated expression of E2F-1 induces hyperplasia and cooperates with ras in skin tumor developments. Oncogene, 16: 1267-1276, 1998.
15. Kowalik, T. F., DeGregori, J., Schwartz, J. K., and Nevins, J. R. E2F-1 overexpression in quiescent fibroblasts leads to induction of cellular DNA synthesis and apoptosis. J. Virol., 69: 2491-2500, 1995.
16. Field, S. J., Tsai, F. Y., Kou, F., Zubiaga, A. M., Kaelin, W. G., Livingston, D. M., Orkin, S. H., and Greenberg, M. E. E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell, 85: 549-561, 1996.
17. Yamasaki, L., Jacks, T., Bronson, R., Goillot, E., Harlow, E., and Dyson, N. J. Tumor induction and tissue atrophy in mice lacking E2F-1. Cell, 85: 537-548, 1996.
18. Pan, H., Yin, C., Dyson, N. J., Harlow, E., Yamasaki, L., and VanDyke, T. Key roles for E2F-1 in signaling p53-dependent apoptosis and in cell division within developing tumors. Mol. Cell Biol., 2: 283-292, 1998.
19. Yamasaki, L., Bronson, R., Williams, B. O., Dyson, N. J., Harlow, E., and Jacks, T. Loss of E2F-1 reduces tumorigenesis and extends the lifespan of Rb1(+/-) mice. Nat. Genet., 18: 360-364, 1998.
20. Dong, Y. B., Yang, H. L., Elliott, M. J., Liu, T. J., Stilwell, A., Atienza, C., Jr., and McMasters, K. M. Adenovirus-mediated E2F-1 gene transfer efficiently induces apoptosis in melanoma cells. Cancer (Phila.), 86: 2021-2033, 1999.
21. Hunt, K. K., Deng, J., Liu, T. J., Wilson-Heiner, M., Swisher, S. G., Clayman, G. L., and Hung, M. C. Adenovirus-mediated overexpression of the transcription factor E2F-1 induces apoptosis in human breast and ovarian carcinoma cell lines and does not require p53. Cancer Res., 57: 4722-4726, 1997.
22. Fueyo, J., Gomez-Manzano, C., Yung, W. K., Liu, T. J., Alemany, R., McDonnell, T. J., Shi, X., Rao, J. S., Levin, V. A., and Kyritis, A. P. Overexpression of E2F-1 in glioma triggers apoptosis and suppresses tumor growth in vitro and in vivo. Nat. Med., 4: 685-690, 1998.
23. Frank, D. K., Liu, T. J., Frederick, M. J., and Clayman, G. L. Combination E2F-1 and p53 gene transfer does not enhance growth inhibition in human squamous cell carcinoma of the head and neck. Clin. Cancer Res., 4: 2265-2272, 1998.
24. INK4. Cancer Gene Ther., 3: 357-364, 1996.
25. Oka, M., Hirose, K., Iizuka, N., Aoyagi, K., Yamamoto, K., Abe, T., Hazama, S., and Suzuki, T. Cytokine mRNA expression patterns in human esophageal cancer cell lines. J. Interferon Cytokine Res., 15: 1005-1009, 1995.
26. Oka, M, Iizuka, N., Yamamoto, K., Gondo, T., Abe, T., Hazama, S., Akitomi, Y., Koishihara, Y., Ohsugi, Y., Ooba, Y., Ishihara, T., and Suzuki, T. The influence of interleukin-6 on the growth of human esophageal cancer cell lines. J. Interferon Cytokine Res., 16: 1001-1006, 1996.
27. French, B. A., Mazur, W., Ali, N. M., Geske, R. S., Finnigan, J. P., and Rodgers, G. P. Percutaneous transluminal in vivo gene transfer by recombinant adenovirus in normal porcine coronary arteries, atherosclerotic arteries, and two models of coronary restenosis. Circulation, 90: 2402-2413, 1994.
28. Graham, F. L., and Prevec, L. Manipulation of Adenovirus Vectors: Methods in Molecular Biology. E. J. Murray (ed.), pp. 109-128. Clifton, NJ: The Humana Press Inc., 1991.
29. Adams, D. O., Edelson, P. H., and Korren, M. S. Methods for studying mononuclear phagocytes: histochemical stains for macrophages in cell smears and tissue sections: β-galactosidase, acid phosphatase, nonspecific esterase, succinate dehydrogenase, and cytochrome oxidase, pp. 375-396. New York: Academic Press, 1981.
30. Lock, R. B., Galperina, O. V., Feldhoff, R. C., and Rhodes, L. J. Concentration-dependent differences in the mechanisms by which caffeine potentiates etoposide cytotoxicity in HeLa cells. Cancer Res., 54: 4933-4939, 1994.
31. Gavriell, Y., Sherman, Y., and Ben-Sasson, S. A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol., 3: 493-501, 1992.
32. He, J., Whitacre, C. M., Xue, L. Y., Berger, N. A., and Oleinick, N. L. Protease activation and cleavage of poly(ADP-ribose) polymerase: an integral part of apoptosis in response to photodynamic treatment. Cancer Res., 58: 940-946, 1998.
33. Stuurman, N., Meijne, A. M., van der Pol, A. J., de Jong, L., van Driel, R., and van Renswoude, J. The nuclear matrix from cells of different origin. Evidence for a common set of matrix proteins. J. Biol. Chem., 265; 5460-5365, 1990.
34. Nishihira, T., Hashimoto, Y., Katayama, M., Mori, S., and Kuroki, T. Molecular and cellular features of esophageal cancer cells. J. Cancer Res. Clin. Oncol., 119: 441-449, 1993.
35. Yamada, Y., Yoshida, T., Hayashi, K., Sekiya, T., Yokota, J., Hirohashi, S., Nakatani, K., Nakano, H., Sugmura, T., and Terada, M. p53 gene mutations in gastric-cancer metastases and in gastri-cancer cells lines derived from metastases. Cancer Res., 51: 5800-5805, 1991.
36. Yang, H. L., Dong, Y. B., Elliott, M. J., Liu, T. J., Stilwell, A., Atienza, C., Jr., and McMasters, K. M. Adenovirus-mediated E2F-1 gene transfer inhibits MDM2-expression and efficiently induces apoptosis in MDM2-overexpressing tumor cells. Clin. Cancer Res., 6: 2242-2250, 1999.
37. Barnas, C., Martel-Planche, G., Furukawa, Y., Hollstein, M., Monetesano. R., and Hainaut. P. Inactivation of the p53 protein in cell lines derived from human esophageal cancers. Int. J. Cancer, 71: 79-87, 1997.
38. Hsieh, J. K., Fredersdorf, S., Kouzarides, T., Martin, K., and Lu, X. E2F-1-induced apoptosis requires DNA binding but not transactivation and is inhibited by the retinoblastoma protein through direct interaction. Genes Dev., 11: 1840-1852, 1997.
39. Sato, T., Hanada, M., Bodrug, S., Irie, S., Iwama, N., Boise, L. H., Thompson, C. B., Golemis, E., Fong, L., Wang, H., and Reed, J. C. Interactions among members of the bcl-2 protein family analyzed with a yeast two-hybrid system. Proc. Natl. Acad. Sci. USA, 91: 9238-9242, 1994.
40. Sedlak, T. W., Oltvai, Z. N., Yang, E., Wang, K., Boise, L. H., Thompson, C. B., and Korsmeyer, S. J. Multiple Bcl-2 family members demonstrate selective dimerization with Bax. Proc. Natl. Acad. Sci. USA, 92: 7834-7838, 1995.
41. Evan, G. I., Brown, L., Whyte, M., and Harrington, E. Review. Apoptosis and the cell cycle. Curr. Opin. in Cell Biol., 7: 825-834, 1995.
42. Wu, X. W., and Levine, A. J. P53 and E2F-1 cooperate to mediate apoptosis. Proc. Natl. Acad. Sci. USA, 91: 3602-3606, 1994.
43. Shan, B., and Lee, W. H. Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis. Mol. Cell Biol., 14: 8166-8173, 1994.
44. Qin, X. O., Livingston, D. M., Kaelin, W. G., Jr., and Adams, P. D. Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc. Natl. Acad. Sci. USA, 91: 10918-10922, 1994.
45. Hiebert, S. W., Packham, G., Strom, D. K., Haffner, R., Oren, M., and Zamebetti, G. E2F-1: DP-1 induces p53 and overrides survival factors to trigger apoptosis. Mol. Cell Biol., 15: 6864-6874, 1995.
46. Gomez-Manzano, C., Fueyo, J., Alameda, F., Kyritsis, A. P., and Yung, W. K. Gene therapy for gliomas: p53 and E2F-1 proteins and the target of apoptosis. Int. J. Mol. Med., 3: 81-85, 1999.
47. Nip, J., Strom, D. K., Fee, B. E., Zambetti, G., Cleveland, J., and Jiebert, S. W. E2F-1 cooperates with topoisomerase II inhibitor and DNA damage to selectively augment p53-independent apoptosis. Mol. Cell Biol., 17: 1049-1056, 1997.
48. Holmberg, C., Helin, K., Sehested, M., and Karlstrom, O. E2F-1-induced p53-independent apoptosis in transgenic mice. Oncogene, 17: 143-155, 1998.
49. Weinber, R. A. The retinoblastoma protein and cell cycle control. Cell, 81: 323-330, 1995.
50. Bagchi, S., Weinmann, R., and Raychaudhuri, P. The retinoblastoma protein copurifies with E2F-1, an E1-A-regulated inhibitor of the transcription factor E2F-1. Cell, 65: 1053-1061, 1991.
51. Oltvai, Z. N., Milliman, C. L., and Korsmeyer, S. J. Bcl-2 heterodimerizes in vivo with a conserved homologue. Bax, that accelerates programmed cell death. Cell, 74: 609-619, 1993.
52. Boise, L. H., Gonzalez, G. M., Postema, C. E., Ding, L., Lindsten, T., Turka, L. A., Mao, X., Nunez, G., and Thompson, C. B. Bcl-X, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell, 74: 697-608, 1993.
53. Hanada, M., Aime, S. C., and Sato, T. Structure-function analysis of Bcl-2 protein. Identification of conserved domains important for homodimerization with Bcl-2 and heterodimerization with Bax. J. Biol. Chem., 270: 11962-11969, 1995.
54. Chittenden, T., Harrington, E. A., O'Connor, R., Flemington, C., Lutz, R. J., Evan, G. I., and Guild, B. C. Induction of apoptosis by the Bcl-2 homologue Bak. Nature (Lond.), 373: 733-736, 1995.
55. Kiefer, M. C., Brauer, M. J., Powers, V. C., Wu, J. J., Ubansky, S. R., Tomei, L. D., and Barr, P. J. Modulations of apoptosis by the widely distributed Bcl-2 homologue Bak. Nature (Lond.), 374: 736-739, 1995.
56. Duan, H., Chinnaiyan, A. M., Hudson, P. L., Wing, J. P., He, W. W., and Dixit, V. M. ICE-LAP3, a novel mammalian homologue of the Caenorhabditis elegans cell death protein Ced-3 is activated during Fas- and tumor necrosis factor-induced apoptosis. J. Biol. Chem., 271: 1621-1625, 1996.
57. Wood, D. E., and Newcomb, E. W. Caspase-dependent activation of calpain during drug-induced apoptosis. J. Biol. Chem., 274: 8309-8315, 1999.